Stay updated on Vadadustat Efficacy in DD-CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the Vadadustat Efficacy in DD-CKD Anemia Clinical Trial page.

Latest updates to the Vadadustat Efficacy in DD-CKD Anemia Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1, with no visible change to the study record.SummaryDifference0.0%

- Check12 days agoChange DetectedThe record now presents details of the completed Phase 3 study comparing vadadustat with darbepoetin alfa for anemia in dialysis-dependent chronic kidney disease, including eligibility, outcomes, locations, results-related information, and study documents.SummaryDifference100%

- Check19 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the study record remains unavailable behind a 403 Forbidden message.SummaryDifference0.2%

- Check33 days agoChange DetectedA sitewide NIH announcement about its website transition appears above the ClinicalTrials.gov 403 error page. The footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check47 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, replacing the study record with an error page and a Home button. This prevents access to the study's details and associated information.SummaryDifference18%

Stay in the know with updates to Vadadustat Efficacy in DD-CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vadadustat Efficacy in DD-CKD Anemia Clinical Trial page.